TianYu Bio-Technology Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	166.63	153.39	178.05	151.6	287.73	305.66
Trading Asset Securities	6.36	-	-	-	-	-
Cash & Short-Term Investments	172.99	153.39	178.05	151.6	287.73	305.66
Cash Growth	18.55%	-13.85%	17.44%	-47.31%	-5.87%	68.44%
Accounts Receivable	397.7	402.96	735.89	893.69	1,033	1,382
Other Receivables	97.64	299.7	258.93	307.38	294.37	296.99
Receivables	495.34	702.66	994.82	1,201	1,327	1,679
Inventory	202.78	224.71	223.77	159.63	239.74	105.95
Other Current Assets	197.94	45.72	56.16	115.17	59.85	132.42
Total Current Assets	1,069	1,126	1,453	1,627	1,914	2,223
Property, Plant & Equipment	483	533.42	533.56	521.79	361.86	233.26
Long-Term Investments	99.91	101.87	97.5	101.67	255.83	96.63
Goodwill	1.52	1.52	2.08	5.56	5.56	5
Other Intangible Assets	24.4	25.15	26.15	7.12	7.82	104.93
Long-Term Accounts Receivable	-	639.67	613.03	452.24	309.12	129.08
Long-Term Deferred Tax Assets	104.8	102.05	105.4	109.43	92.12	46.83
Long-Term Deferred Charges	7.73	5.62	4.95	5.3	4.65	3.59
Other Long-Term Assets	900.96	258.49	279.51	342.06	409.89	486.69
Total Assets	2,691	2,893	3,215	3,273	3,461	3,329

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	632.05	683.15	638.33	684	666.01	684.18
Accrued Expenses	43.15	31.08	28.24	19.38	16.59	6.62
Short-Term Debt	118.12	164.07	128.23	168.35	152.76	216.34
Current Portion of Long-Term Debt	156.52	93.73	115.51	77.61	39.39	311.02
Current Portion of Leases	-	13.32	35.94	25.94	33.71	6.31
Current Income Taxes Payable	3.07	2.62	0.05	-	1.35	2.28
Current Unearned Revenue	77.66	79.15	144.65	82.5	71.63	80.07
Other Current Liabilities	221.62	258.51	255.4	180.37	149.4	117.15
Total Current Liabilities	1,252	1,326	1,346	1,238	1,131	1,424
Long-Term Debt	658.63	692.14	753.37	751.37	649.16	212.11
Long-Term Leases	124.77	144.89	247.13	281.18	209.79	41
Long-Term Unearned Revenue	0.55	0.61	0.69	-	-	-
Long-Term Deferred Tax Liabilities	2.27	2.45	2.68	0.07	0.26	0.58
Other Long-Term Liabilities	137.87	133.77	156.24	167.5	36.79	39.59
Total Liabilities	2,176	2,299	2,506	2,438	2,027	1,717

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	290.15	290.15	290.15	290.15	290.15	290.15
Additional Paid-In Capital	892.74	912.8	912.21	931.77	931.9	930.16
Retained Earnings	-879.36	-790.52	-683.62	-576.26	-81.85	197.55
Total Common Equity	303.52	412.42	518.74	645.66	1,140	1,418
Minority Interest	211.57	181.22	189.79	188.69	293.53	193.73
Shareholders' Equity	515.09	593.64	708.53	834.35	1,434	1,612
Total Liabilities & Equity	2,691	2,893	3,215	3,273	3,461	3,329

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	1,058	1,108	1,280	1,304	1,085	786.78
Net Cash (Debt)	-885.05	-954.76	-1,102	-1,153	-797.09	-481.12
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-3.05	-3.29	-3.80	-3.97	-3.30	-1.81
Filing Date Shares Outstanding	290.09	290.15	290.15	290.15	290.15	290.15
Total Common Shares Outstanding	290.09	290.15	290.15	290.15	290.15	290.15
Working Capital	-183.15	-199.15	106.45	389.31	783.56	798.86
Book Value Per Share	1.05	1.42	1.79	2.23	3.93	4.89
Tangible Book Value	277.6	385.76	490.5	632.98	1,127	1,308
Tangible Book Value Per Share	0.96	1.33	1.69	2.18	3.88	4.51
Buildings	-	158.14	150.56	98.24	7.96	176.46
Machinery	-	275.01	245.82	209.27	88.56	31.86
Construction In Progress	-	35.66	21.37	19.06	7.37	3.93